Biointron

Founded in 2012 and certified to ISO 9001:2015, Biointron is a CRO specializing in antibody discovery, expression, and optimization services for biotech and pharmaceutical companies.
​
Purchase on Scientist.com
​

Subscribe to our newsletter

Subscribe to receive the latest news and innovations straight to your inbox.

The Latest Insights & Innovations from

Biointron

Webinars
Blogs
Podcasts
​
ON DEMAND
​
Webinar

Accelerating Antibody Discovery: Integrating Microfluidics, HT Expression, and Early Developability Platform

April 30, 2026
Learn more
​
ON DEMAND
​
Webinar

From Single Domain to Single B: Leveraging Biointron's Expertise for Antibody Discovery Success

October 16, 2025
Learn more
​
ON DEMAND
​
Webinar

Introduction to Bispecific Antibodies and Their Production

May 15, 2025
Learn more
​
Blog

The Case for Early Developability Assessment in Antibody Discovery

December 9, 2025
Learn more
​
Blog

From Target to Therapeutic: Rethinking Antibody Discovery

September 25, 2025
Learn more
​
Blog

The Role of Recombinant Antibody Platforms in Advancing Therapeutic Development: Key Insights and Considerations for Production Success

August 21, 2025
Learn more
No items found.
​
See it in Action

The Digital Backbone for Modern Life Sciences

Discover how one intelligent platform helps teams connect providers, workflows, approvals, compliance, data, and spend—so complex projects move faster with greater visibility and control.

​
Request a Personalized Demo